Related Experiment Video
Updated: Jul 10, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Cerebral metastasis from hepatoid adenocarcinoma of the stomach
Sheng Zhang1, Mi Wang, Yi-Hui Xue
1Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China. zhgshg@126.com
Insights
This report details a rare case of gastric hepatoid adenocarcinoma (HAC) metastasizing to the brain. Accurate diagnosis using immunohistochemistry is crucial to differentiate from hepatocellular carcinoma (HCC) brain metastases.
Area of Science:
- Gastroenterology and Oncology
- Neuropathology
- Medical Imaging
Background:
- Gastric adenocarcinoma can rarely metastasize to the brain.
- Hepatoid adenocarcinoma (HAC) is a rare subtype of gastric cancer with distinct histopathological features.
- Accurate differentiation of brain metastases is critical for appropriate patient management.
Observation:
- A 50-year-old patient presented with neurological symptoms including headache and visual disturbances.
- MR imaging revealed a brain lesion consistent with a metastatic tumor.
- The patient had a prior history of gastric adenocarcinoma treated with gastrectomy and subsequent liver metastasis management.
Findings:
- Histopathological and immunohistochemical analysis confirmed the brain tumor was identical to the primary gastric tumor.
- Tumor cells were positive for alpha-fetoprotein (AFP) and negative for Hep-Par-1, consistent with HAC.
- The diagnosis was metastatic gastric hepatoid adenocarcinoma (HAC).
Implications:
- This case highlights the importance of considering rare metastatic patterns of gastric cancer.
- Immunohistochemistry, particularly using AFP and Hep-Par-1, is essential for differentiating gastric HAC brain metastases from hepatocellular carcinoma (HCC) metastases.
- Early and accurate diagnosis can guide treatment strategies and improve patient outcomes.
Abstract:
We first report a rare case of metastasis from gastric hepatoid adenocarcinoma (HAC) to cerebral parenchyma, in a 50-year-old Chinese patient. He complained of a one-month history of a paroxysm of headache in the left temple and pars parietalis accompanied with binocular caligation caligo, insensible feeling of limbs and transient anepia. Magnetic resonance (MR) imaging revealed a spherical occupying lesion in the left posterior-temple lobe which was clinically diagnosed as a metastatic tumor. Three years ago, the patient accepted total gastrectomy as he was pathologically diagnosed at gastroscopy having an adenocarcinoma. Eight months after gastrectomy, the occupying lesion in liver was detected by ultrasound and CT, and he accepted transcatheter arterial embolization. Before operation of the brain metastasis, no obvious abnormality was found in liver by ultrasound. Histopathological characteristics of the brain tumor were identical to those of stomach tumor. The growth pattern of both tumors showed solid cell nests. The tumor cells were polygonal, and had abundant eosinophilic cytoplasm and round nuclei with obvious nucleoli. Sinusoid-like blood spaces were located between nodular tumor cells. Immunohistochemistry-stained tumor cells were positive for AFP and negative for Hep-Par-1. According to these histopathological findings, both tumors were diagnosed as HAC and metastatic HAC. The patient remained alive 16 mo after tumorectomy of the cerebral metastasis. The differential diagnosis of brain metastasis from metastatic tumors should use a panel of antibodies to avoid confusing with the brain metastasis of hepatocellular carcinoma (HCC). This paper describes this rare case of metastasis from gastric hepatoid adenocarcinoma to cerebral parenchyma, and provides a review of the literature concerning its histopathological and immunohistochemical characteristics.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hepatic Encephalopathy

